Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Renal Insufficiency, Chronic 1Non-alcoholic Fatty Liver Disease 1Liver Cirrhosis, Alcoholic 1Hypothermia 1Hepatitis C 1Hepatitis B 1Fibrosis 1End Stage Liver Disease 1Carcinoma, Hepatocellular 1Acute Kidney Injury 1

Interventions

daratumumab 2Urination 2Plasma Exchange 2sodium sulfate 1glucarpidase 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Stents 1Spironolactone 1Renal Replacement Therapy 1Renal Dialysis 1Nephrotomy 1Nephrostomy, Percutaneous 1Methotrexate 1Ischemic Preconditioning 1Hypothermia, Induced 1Hyperthermic Intraperitoneal Chemotherapy 1Hemodiafiltration 1Drug Therapy 1Cisplatin 1Cilastatin 1Antibiotic Prophylaxis 1Anesthetics 1Aminophylline 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acute Kidney Injury × Hypothermia, Induced × Genitourinary × Clear all
NCT03534141 2025-05-16

MHALT

University of California, San Francisco

Phase NA Terminated
175 enrolled 19 charts
GastrointestinalGenitourinary

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡